The role of HDL cholesterol in metabolic syndrome predicting cardiovascular events. The Gubbio population study

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 21, Issue 5, 2011, Pages 315-322

  Menotti, A ^a   Lanti, M ^a   Zanchetti, A ^b   Botta, G ^c   Laurenzi, M ^d   Terradura Vagnarelli, O ^e   Mancini, M ^f  

^a Association for Cardiac Research Associazione per la Ricerca Cardiologica   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c Merck Research Laboratories   (Italy)

^d GLOBAL ALLIANCE FOR TB DRUG DEVELOPMENT   (United States)

^e Centre of Preventive Medicine   (Italy)

^f UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Cardiovascular events; HDL cholesterol; Metabolic syndrome; Prediction

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ARTICLE; BLOOD; BLOOD PRESSURE; COHORT ANALYSIS; CORONARY ARTERY DISEASE; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HUMAN; ITALY; MALE; METABOLIC SYNDROME X; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREDICTIVE VALUE; PREVALENCE; RISK ASSESSMENT; RISK FACTOR; SMOKING; THEORETICAL MODEL;

ADULT; AGED; BLOOD GLUCOSE; BLOOD PRESSURE; CHOLESTEROL, HDL; COHORT STUDIES; CORONARY DISEASE; FEMALE; FOLLOW-UP STUDIES; HUMANS; ITALY; MALE; METABOLIC SYNDROME X; MIDDLE AGED; MODELS, THEORETICAL; MULTIVARIATE ANALYSIS; PREDICTIVE VALUE OF TESTS; PREVALENCE; RISK ASSESSMENT; RISK FACTORS; SMOKING;

EID: 79954632772     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.numecd.2009.11.001     Document Type: Article

References (44)

1. Key words: Metabolic Syndrome. [accessed June 2009]. http://www.pubmed.org.
2. Trevisan M., Liu J., Bahsas F.B. Menotti A for the risk factor and life expectancy research group. Syndrome X and mortality: a population based study. Am J Epidemiol 1998, 148:958-966.
3. Lakka H.M., Laaksonen D.E., Lakka T.A., Niskanen L.K., Kumpusalo E., Tuomilehto J., et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 2002, 288:2709-2715.
4. Bonora E., Kiechl S., Willeit J., Oberhollenzer E., Egger G., Bonadonna R.C., et al. Carotid atherosclerosis and coronary heart disease in the metabolic syndrome: prospective data from the Brunek study. Diabetes Care 2003, 26:1251-1257.
5. Ridker P.M., Buring J.E., Cook N.R., Rifai N. C-reactive protein, the metabolic syndrome and risk of incident cardiovascular events: an 8-year follow-up of 14719 initially health American women. Circulation 2003, 107:391-397.
6. Ford E.S. The metabolic syndrome and mortality from cardiovascular disease and all-cause findings from the National Health and Nutrition Examination Survey II Mortality Study. Atherosclerosis 2004, 173:309-314.
7. Hunt K.J., Resendez R., Williams K., Haffner S.M., Stern M.P. National Cholesterol Education Program versus World Health Organization metabolic syndrome in relation to all-cause and cardiovascular mortality in the San Antonio Heart Study. Circulation 2004, 110:1251-1257.
8. Malik S., Wong N.D., Franklin S.S., Kamath T.V., L'Italien G.J., Pio J.R., et al. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular and all causes in United States adults. Circulation 2004, 110:1245-1250.
9. McNeill A.M., Rosamond W.D., Girman C.J., Golden S.H., Schmidt M.I., East H.E., et al. The metabolic syndrome and 11-year risk of incident cardiovascular disease in atherosclerosis risk in communities. Diabetes Care 2005, 28:385-390.
10. Maggi S., Noale M., Gallina P., Bianchi D., Marzari C., Limongi F., et al. ILSA Working Group. Metabolic syndrome, diabetes, and cardiovascular disease in an elderly Caucasian colour: the Italian Longitudinal Study on Aging. J Gerontol A Biol Sci Med Sci 2006, 61:505-510.
11. Gami A.S., Witt B.J., Howard D.E., Erwin P.J., Gami L.A., Somers V.K., et al. Metabolic syndrome and risk of cardiovascular events and death. A systematic review and meta-analysis of longitudinal studies. J Am Coll Cardiol 2007, 49:403-414.
12. Kahn R., Buse J., Ferranini E., Stern M. The metabolic syndrome. Time for a critical appraisal. Joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2005, 28:2289-2304.
13. Mancia G., Bombelli M., Corrao G., Facchetti R., Madotto F., Giannattasio C., et al. Metabolic syndrome in the Pressioni Arteriose Monitorate E Loro Associazioni (PAMELA) study: daily life blood pressure, cardiac damage, and prognosis. Hypertension 2007, 9:10-12.
14. National Cholesterol Education Program (NCEP) Expert Panel on Detection Evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). Third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III) final report. Circulation 2002, 106:3143-3421.
15. Alberti K.G., Zimmer P., Shaw J. The IDF Epidemiological Task Force Consensus Group. The metabolic syndrome: a new worldwide definition. Lancet 2005, 336:1059-1062.
16. Balkau B., Charles M.A. Comments of the provisional report from the WHO consultation. European Group for the Study of Insulin Resistance (EGIR). Diabet Med 1999, 16:442-443.
17. Alberti K.G., Zimmer P.Z. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1. Diagnosis and classification of diabetes mellitus: provisional report of a WHO consultation. Diabet Med 1998, 15:539-553.
18. Abbott R.D., Wilson P.W., Kannel W.B., Castelli W.P. High density lipoprotein cholesterol, total cholesterol screening, and myocardial infarction. The Framingham Study. Arteriosclerosis (Dallas, Tex) 1988, 8:207-211.
19. Assmann G., Schulte H., von Eckardstein A., Huang Y. High-density lipoprotein cholesterol as a predictor of coronary heart disease risk. The PROCAM experience and pathophysiological implications for reverse cholesterol transport. Atherosclerosis 1996, 124(Suppl.):S11-S20.
20. Goldbourt U. HDL cholesterol and 24-year mortality. Int J Epidemiol 1986, 15:143-144.
21. Jousilahti P., Vartiainen E., Tuomilehto J., Puska P. Sex, age, cardiovascular risk factors, and coronary heart disease: a prospective follow-up study of 14 786 middle-aged men and women in Finland. Circulation 1999, 99(9):1165-1172.
22. Kitamura A., Iso H., Naito Y., Iida M., Konishi M., Folsom A.R., et al. High-density lipoprotein cholesterol and premature coronary heart disease in urban Japanese men. Circulation 1994, 89(6):2533-2539.
23. Luc G., Bard J.M., Ferrieres J., Evans A., Amouyel P., Arveiler D., et al. Value of HDL cholesterol, apolipoprotein A-I, lipoprotein A-I, and lipoprotein A-I/A-II in prediction of coronary heart disease: the PRIME Study. Prospective Epidemiological Study of Myocardial Infarction. Arterioscler Thromb Vasc Biol 2002, 22(7):1155-1161.
24. Miller G.J., Miller N.E. Plasma-high-density-lipoprotein concentration and development of ischaemic heart-disease. Lancet 1975, 1(7897):16-19.
25. Sharrett A.R., Ballantyne C.M., Coady S.A., Heiss G., Sorlie P.D., Catellier D., et al. Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein(a), apolipoproteins A-I and B, and HDL density subfractions: The Atherosclerosis Risk in Communities (ARIC) Study. Circulation 2001, 104(10):1108-1113.
26. Stensvold I., Urdal P., Thurmer H., Tverdal A., Lund-Larsen P.G., Foss O.P. High-density lipoprotein cholesterol and coronary, cardiovascular and all cause mortality among middle-aged Norwegian men and women. Eur Heart J 1992, 13(9):1155-1163.
27. Menotti A., Spagnolo A., Scanga M., Dima F. Multivariate prediction of coronary deaths in a 10 year follow-up of an Italian occupational male cohort. Acta Cardiol 1992, 47:311-320.
28. Menotti A., Lanti M., Puddu P.E., Mancini M., Zanchetti A., Cirillo M., et al. First risk functions for prediction of coronary and cardiovascular disease incidence in the Gubbio Population Study. Ital Heart J 2000, 1:394-399.
29. Menotti A., Lanti M., Agabiti-Rosei E., Carratelli L., Cavera G., Dormi A., et al. New tools for prediction of cardiovascular disease risk derived from Italian population studies. Nutr Metab Cardiovasc Dis 2005, 15:426-440.
30. Palmieri L., Donfrancesco C., Giampaoli S., Trojani M., Panico S., Vanuzzo D., et al. Favorable cardiovascular risk profile and 10-year coronary heart disease incidence in women and men: results from the Progetto Cuore. Eur J Cardiovasc Prev Rehabil 2006, 13:562-570.
31. Blood cholesterol and vascular mortality by age, sex and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55000 vascular deaths. Lancet 2007, 370:1829-1839. Prospective Studies Collaboration.
32. Cooney M.T., Dudina A., De Bacquer D., Wilhelmsen L., Sans S., Menotti A., et al. HDL cholesterol protects against cardiovascular disease in both genders, at all ages and at all levels of risk. Atherosclerosis 2009, March 19th, (Epub ahead of print).
33. Barter Ph, Rye K.A. High density cholesterol: the new target. A handbook for clinicians 2005, Sherborne Gibbs Limited, Birmingham, UK.
34. Carlson L.A. Niaspan, the prolonged release preparation of nicotinic acid (niacin), the broad-spectrum lipid drug. Int J Clin Pract 2004, 58:706-713.
35. Laurenzi M., Trevisan M. Sodium-lithium countertransport and blood pressure: the Gubbio Population Study. Hypertension 1989, 13:408-415.
36. Laurenzi M., Cirillo M., Panarelli W., Trevisan M., Stamler R., Dyer A.R., et al. Baseline sodium-lithium countertransport and 6-year incidence of hypertension: the Gubbio Study. Circulation 1997, 95:581-587.
37. Menotti A., Lanti M., Angeletti M., Botta G.F., Cirillo M., Laurenzi M., et al. Twenty-year cardiovascular and all-cause mortality trends, and changes in cardiovascular risk factors in Gubbio, Italy. The role of blood pressure changes. J Hypertens 2009, 27:266-274.
38. Rose G., Blackburn H. Cardiovascular survey methods 1968, World Health Organization, Geneva.
39. Morisi G., Macchia T., Angelico P., Pacioni F., Zucca A. Determinazione automatica di trigliceridi, colesterolo, glucosio ed acido urico: prospettive d'impiego in screening di medicina preventiva. Ann Ist Super Sanita 1979, 15:239-261.
40. Buongiorno A.M., Macchia T., Morisi G., Zucca A. HDL colesterolo:confronto tra metodi e prospettive di impiego nella prevenzione dell'arteriosclerosi. G Ital Chim Clin 1982, 7:127-138.
41. World Health Organization International classification of diseases and causes of death 1975, WHO, Geneva. 9th Revision.
42. Reaven G.M. The metabolic syndrome: requiescat in pace. Clin Chem 2005, 51:931-938.
43. Grundy S.M. The metabolic syndrome is still alive. Clin Chem 2005, 51:1352-1357.
44. Menotti A., Lanti M. The metabolic syndrome, the Guy syndrome and the hypofit syndrome. J Cardiovasc Med 2007, 8:397-398.